The Use of Stability Modelling to Support Accelerated Vaccine Development...

Presented by

Didier Clenet, Jos Weusten, Marilena Paludi and Cristiana Campa

About this talk

The Use of Stability Modelling to Support Accelerated Vaccine Development & Supply Stability assessment is particularly relevant for vaccines, due to the typical need for cold storage to remain stable. When stability evaluation is exclusively based on real-time data, it may represent a bottleneck for rapid and effective vaccine access. Stability modeling for vaccines represents a key resource to predict stability based on accelerated stability studies. This Webinar session reports a cross-company perspective on stability modeling for vaccines, demonstrating  that modeling approaches can be highly valuable to predict vaccines’ shelf life and behavior during shipment or manipulation. Also, it is demonstrated that modeling methodologies need to be tailored to the nature of the vaccine, the available prior knowledge, and the monitored attributes.   Presented by Didier Clenet, Research Scientist Formulation & Stability chez Sanofi Pasteur, Jos Weusten, Senior Statistician and Applied Mathematician at MSD (Oss, The Netherlands), Marilena Paludi, Lead Statistician presso GSK, and Cristiana Campa, Technical R&D Advisor at GSK

Related topics:

More from this channel

Upcoming talks (25)
On-demand talks (284)
Subscribers (27354)
BioPharma Webinars aims to keep its 30,000 readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.